Navigation Links
Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Date:8/25/2009

vessels (veins), especially in your leg (deep venous thrombosis or DVT). Pieces of a blood clot may travel to the lungs and block the blood circulation in the lungs (pulmonary embolus).

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
2. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
3. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
6. Medarex to Receive Milestone Payment from Amgen
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
10. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
11. Bionovo Announces Second Quarter 2009 Highlights and Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Pipettes & Pipettors - ...portlinker.com/p0164373/Pipettes--Pipettors---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...gral part of any research laboratory. Large-scale ...
(Date:11/20/2009)... and LONDON, Nov. 20 Bos...nounced that it has received 510(k) clearance from...E Mark approval to market its WallFlex® Fully...ignant esophageal strictures (obstructions) caused...ctable esophageal cancer. ,, (Photo: http://...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Fruit juices contain more vitamin C than their labels indicate 58852 1Fruit juices contain more vitamin C than their labels indicate 58852 2Focused Radiation Protects Tumor Patients Brain Function 58850 1Focused Radiation Protects Tumor Patients Brain Function 58850 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 1Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 3Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 4
...and,worldwide leader in radiation treatment planni...ced that three sites have delivered clinical,treat...tensity Modulated,Radiotherapy (IMRT) treatment pl...burgh, Pennsylvania, Erasmus Medical Center in Rot...n Hospital in Milwaukee,Wisconsin, have all begun ...
...Clinical Profile of This Novel,Anti-Cancer Agent U...ts,With Hormone Refractory Prostate Cancer (HRPC),...herapeutics company,today announced that the prima...n study was met. The study showed that even single... metastases could produce,increasing clinical bene...
Other Medicine Technology:CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 3Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 4
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game, S... Touch. , Mountain View, ... popular and addictive game, SplitWords, is now av...is designed to help banish that ,tip of the tongue...ain game challenges the brain by encouraging user...
(Date:11/20/2009)...J, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharma...ting of Shareholders will be held on Monday, Decem...sider approval of two special resolutions. The fir...the sale of all or substantially all of the assets...or in the asset purchase agreement dated November ...
(Date:11/20/2009)....J., Nov. 20 Rates of in...peaked in late October, but the pandemic flu virus...all age groups, including the elderly, according t...NYSE: DGX ), the world,s leading provider of dia...In its most recent Quest Diagnostics Health Trends...
(Date:11/20/2009).... 20 The following is a... the Nevada Health Care Association: ,, "The Ne...hanks Senate Majority Leader Harry Reid for his le... our goal of protecting every Nevada seniors, ongo...rving the strength and viability of our state,s vi...
(Date:11/20/2009)...November 20, 2009Emergency medical service (EMS) p...350,000 cardiac arrests each year. Only 5 to 10 p...rvive. Better quality cardiopulmonary resuscitati... be associated with better patient outcome. The R...est clinical research network to study prehospital...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...ashington, DC (Thursday, June 19, 2008) Healthy i... considered normal, are at risk for developing chr...pearing in the September 2008 issue of the Journa...in, including diabetes and hypertension. , Resear...
...Cell phones, Blackberries, e-mail, laptops allowin...ng in perfectly condensed and filtered snippets vi...ion been so instantaneous and information distribu...omote a well-informed and close-knit society. Whil...
...NDIANAPOLIS Indiana University School of Medicine...ector Biorepository and Coordinating Center (NGVB)...million grant from the National Institutes of Heal...cine and of microbiology and immunology. The three...
...VILLE, Md., June 19 Pastillas para la,diabetes ti... have type 2,diabetes and need information to help...llness, has been released by the Agency for Health...n eight Hispanics take a,prescription drug for dia...
...DIEGO, June 19 Sydney company, Seagull Technology...ry device that reduces the,risks associated with t...ness and severe vision loss -- Age Related Macular...ltrasound (sound,waves) in a handheld device to se...
...IRIE, La., June 19 OrthoSynetics(TM), the largest...dental practices,worldwide, has beefed up its mark...g professional to its team. Katherine Staiano has ...onals to our team to,provide our doctors creative ...
Other Medicine News:Health News:Weight gain within the normal range increases risk of chronic kidney disease 2Health News:Unable to focus? Welcome to our distracted society's attention deficit 2Health News:Unable to focus? Welcome to our distracted society's attention deficit 3Health News:Unable to focus? Welcome to our distracted society's attention deficit 4Health News:Indiana University to host national biorepository for gene therapy 2Health News:New Spanish-Language Consumer Guide Compares Oral Diabetes Medications 2Health News:Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: